These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27626483)

  • 21. HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).
    Xu J; Lange EM; Lu L; Zheng SL; Wang Z; Thibodeau SN; Cannon-Albright LA; Teerlink CC; Camp NJ; Johnson AM; Zuhlke KA; Stanford JL; Ostrander EA; Wiley KE; Isaacs SD; Walsh PC; Maier C; Luedeke M; Vogel W; Schleutker J; Wahlfors T; Tammela T; Schaid D; McDonnell SK; DeRycke MS; Cancel-Tassin G; Cussenot O; Wiklund F; Grönberg H; Eeles R; Easton D; Kote-Jarai Z; Whittemore AS; Hsieh CL; Giles GG; Hopper JL; Severi G; Catalona WJ; Mandal D; Ledet E; Foulkes WD; Hamel N; Mahle L; Moller P; Powell I; Bailey-Wilson JE; Carpten JD; Seminara D; Cooney KA; Isaacs WB;
    Hum Genet; 2013 Jan; 132(1):5-14. PubMed ID: 23064873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men.
    Lin X; Qu L; Chen Z; Xu C; Ye D; Shao Q; Wang X; Qi J; Chen Z; Zhou F; Wang M; Wang Z; He D; Wu D; Gao X; Yuan J; Wang G; Xu Y; Wang G; Dong P; Jiao Y; Yang J; Ou-Yang J; Jiang H; Zhu Y; Ren S; Zhang Z; Yin C; Wu Q; Zheng Y; Turner AR; Tao S; Na R; Ding Q; Lu D; Shi R; Sun J; Liu F; Zheng SL; Mo Z; Sun Y; Xu J
    Prostate; 2013 Jan; 73(2):169-75. PubMed ID: 22718278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland.
    Kluźniak W; Wokołorczyk D; Kashyap A; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dębniak T; Gołąb A; Gliniewicz B; Sikorski A; Switała J; Borkowski T; Borkowski A; Antczak A; Wojnar L; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Sikorska-Radek P; Matych J; Wilkosz J; Różański W; Kiś J; Bar K; Bryniarski P; Paradysz A; Jersak K; Niemirowicz J; Słupski P; Jarzemski P; Skrzypczyk M; Dobruch J; Domagała P; Akbari MR; Lubiński J; Narod SA; Cybulski C;
    Prostate; 2013 Apr; 73(5):542-8. PubMed ID: 23334858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer.
    Johng D; Torga G; Ewing CM; Jin K; Norris JD; McDonnell DP; Isaacs WB
    Prostate; 2019 Mar; 79(4):414-424. PubMed ID: 30560549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Two Novel HOXB13 Germline Mutations in Portuguese Prostate Cancer Patients.
    Maia S; Cardoso M; Pinto P; Pinheiro M; Santos C; Peixoto A; Bento MJ; Oliveira J; Henrique R; Jerónimo C; Teixeira MR
    PLoS One; 2015; 10(7):e0132728. PubMed ID: 26176944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk.
    Laitinen VH; Wahlfors T; Saaristo L; Rantapero T; Pelttari LM; Kilpivaara O; Laasanen SL; Kallioniemi A; Nevanlinna H; Aaltonen L; Vessella RL; Auvinen A; Visakorpi T; Tammela TL; Schleutker J
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):452-60. PubMed ID: 23292082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey.
    Smith SC; Palanisamy N; Zuhlke KA; Johnson AM; Siddiqui J; Chinnaiyan AM; Kunju LP; Cooney KA; Tomlins SA
    Am J Surg Pathol; 2014 May; 38(5):615-26. PubMed ID: 24722062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic factors influencing prostate cancer risk in Norwegian men.
    Chen H; Ewing CM; Zheng S; Grindedaal EM; Cooney KA; Wiley K; Djurovic S; Andreassen OA; Axcrona K; Mills IG; Xu J; Maehle L; Fosså SD; Isaacs WB
    Prostate; 2018 Feb; 78(3):186-192. PubMed ID: 29181843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation HOXB13 c.853delT in Martinican prostate cancer patients.
    Marlin R; Créoff M; Merle S; Jean-Marie-Flore M; Rose M; Malsa S; Promeyrat X; Martin F; Comlan G; Rabia N; Taouil T; Issoufaly I; Escarmant P; Vinh-Hung V; Béra O
    Prostate; 2020 May; 80(6):463-470. PubMed ID: 32040869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort.
    Hoffmann TJ; Sakoda LC; Shen L; Jorgenson E; Habel LA; Liu J; Kvale MN; Asgari MM; Banda Y; Corley D; Kushi LH; Quesenberry CP; Schaefer C; Van Den Eeden SK; Risch N; Witte JS
    PLoS Genet; 2015 Jan; 11(1):e1004930. PubMed ID: 25629170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population-based estimate of prostate cancer risk for carriers of the HOXB13 missense mutation G84E.
    MacInnis RJ; Severi G; Baglietto L; Dowty JG; Jenkins MA; Southey MC; Hopper JL; Giles GG
    PLoS One; 2013; 8(2):e54727. PubMed ID: 23457453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germline mutations in HOXB13 and prostate-cancer risk.
    Ewing CM; Ray AM; Lange EM; Zuhlke KA; Robbins CM; Tembe WD; Wiley KE; Isaacs SD; Johng D; Wang Y; Bizon C; Yan G; Gielzak M; Partin AW; Shanmugam V; Izatt T; Sinari S; Craig DW; Zheng SL; Walsh PC; Montie JE; Xu J; Carpten JD; Isaacs WB; Cooney KA
    N Engl J Med; 2012 Jan; 366(2):141-9. PubMed ID: 22236224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of the HOXB13 G84E mutation among unaffected men with a family history of prostate cancer.
    Handorf E; Crumpler N; Gross L; Giri VN
    J Genet Couns; 2014 Jun; 23(3):371-6. PubMed ID: 24310616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk.
    Liu J; Prager-van der Smissen WJ; Schmidt MK; Collée JM; Cornelissen S; Lamping R; Nieuwlaat A; Foekens JA; Hooning MJ; Verhoef S; van den Ouweland AM; Hogervorst FB; Martens JW; Hollestelle A
    Sci Rep; 2016 Jul; 6():30026. PubMed ID: 27424772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HOXB13 mutations in a population-based, case-control study of prostate cancer.
    Stott-Miller M; Karyadi DM; Smith T; Kwon EM; Kolb S; Stanford JL; Ostrander EA
    Prostate; 2013 May; 73(6):634-41. PubMed ID: 23129385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational Modeling of complete HOXB13 protein for predicting the functional effect of SNPs and the associated role in hereditary prostate cancer.
    Chandrasekaran G; Hwang EC; Kang TW; Kwon DD; Park K; Lee JJ; Lakshmanan VK
    Sci Rep; 2017 Mar; 7():43830. PubMed ID: 28272408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for familial and hereditary prostate cancer.
    Lynch HT; Kosoko-Lasaki O; Leslie SW; Rendell M; Shaw T; Snyder C; D'Amico AV; Buxbaum S; Isaacs WB; Loeb S; Moul JW; Powell I
    Int J Cancer; 2016 Jun; 138(11):2579-91. PubMed ID: 26638190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.
    Darst BF; Hughley R; Pfennig A; Hazra U; Fan C; Wan P; Sheng X; Xia L; Andrews C; Chen F; Berndt SI; Kote-Jarai Z; Govindasami K; Bensen JT; Ingles SA; Rybicki BA; Nemesure B; John EM; Fowke JH; Huff CD; Strom SS; Isaacs WB; Park JY; Zheng W; Ostrander EA; Walsh PC; Carpten J; Sellers TA; Yamoah K; Murphy AB; Sanderson M; Crawford DC; Gapstur SM; Bush WS; Aldrich MC; Cussenot O; Petrovics G; Cullen J; Neslund-Dudas C; Kittles RA; Xu J; Stern MC; Chokkalingam AP; Multigner L; Parent ME; Menegaux F; Cancel-Tassin G; Kibel AS; Klein EA; Goodman PJ; Stanford JL; Drake BF; Hu JJ; Clark PE; Blanchet P; Casey G; Hennis AJM; Lubwama A; Thompson IM; Leach RJ; Gundell SM; Pooler L; Mohler JL; Fontham ETH; Smith GJ; Taylor JA; Brureau L; Blot WJ; Biritwum R; Tay E; Truelove A; Niwa S; Tettey Y; Varma R; McKean-Cowdin R; Torres M; Jalloh M; Magueye Gueye S; Niang L; Ogunbiyi O; Oladimeji Idowu M; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Yeboah ED; Mensah JE; Anthony Adjei A; Diop H; Cook MB; Chanock SJ; Watya S; Eeles RA; Chiang CWK; Lachance J; Rebbeck TR; Conti DV; Haiman CA
    Eur Urol; 2022 May; 81(5):458-462. PubMed ID: 35031163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer.
    Alanee S; Shah S; Vijai J; Schrader K; Hamilton R; Rau-Murthy R; Sarrel K; Manschreck C; Eastham J; Offit K
    Fam Cancer; 2013 Dec; 12(4):597-600. PubMed ID: 23475555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank.
    Wei J; Shi Z; Na R; Wang CH; Resurreccion WK; Zheng SL; Hulick PJ; Cooney KA; Helfand BT; Isaacs WB; Xu J
    Br J Cancer; 2020 Oct; 123(9):1356-1359. PubMed ID: 32830201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.